Surgeries & Interventions
October 30, 2023
Promising Drug-Coated Balloon Results for In-Stent Restenosis October 30, 2023
The United States has been way behind other nations in using drug-coated balloons to treat coronary in-stent restenosis, but that might change soon thanks to the results from the AGENT IDE Trial.
Artificial Intelligence
October 26, 2023
Healthcare AI Clearances Boom, While Cardiology AI Stalls October 26, 2023
The FDA’s annual Healthcare AI Report had medtech social media buzzing this week, showing that an impressive 692 AI-enabled devices have landed FDA clearance as of July 2023, while revealing an apparent slowdown in cardiovascular AI approvals.
Pharmaceuticals
October 23, 2023
Pemvidutide’s Weight Loss and CVD Evidence October 23, 2023
Interim Phase 2 results from the MOMENTUM trial show that Altimmune’s pemvidutide drove significant weight loss and improved key cardiovascular metrics.
Pharmaceuticals
October 19, 2023
Novo Nordisk Expands CV Pipeline with Ocedurenone Acquisition October 19, 2023
Novo Nordisk took advantage of its semaglutide windfall, expanding its cardiovascular drug pipeline by acquiring ocedurenone from KBP Biosciences for $1.3 billion.
Cardiology
October 13, 2023
GE and Mediport’s One-Stop Cardiology Clinic October 13, 2023
With a direct target on streamlining the cardiovascular care pathway, GE HealthCare and Belgian healthcare organization Mediport announced the launch of the first One-Stop Clinic for Cardiology.
Pharmaceuticals
October 12, 2023
Semaglutide Adds to Cardiovascular Resume October 12, 2023
Semaglutide continued to add to its cardiovascular resume, with two new studies highlighting its ability to improve heart failure symptoms and cardiorenal outcomes.
Value-Based Care
October 9, 2023
CVAUSA and InnovaCare’s Value-Based Alliance October 9, 2023
A new Cardiovascular Associates of America and InnovaCare Health is aiming to create a new model for cardiology + primary care VBC delivery.
Cardiology
October 5, 2023
MedAxiom on the State of Cardiovascular Providers October 5, 2023
MedAxiom just released its 11th annual Compensation and Production Report, revealing general stability in 2022 after years of significant change.
Surgeries & Interventions
October 2, 2023
Adena Health Pauses Cardiac Surgeries Amid Mounting Deaths, Controversies October 2, 2023
Ohio’s Adena Health System has temporarily stopped performing heart surgeries and fired two of its cardiac surgeons, after months of growing scrutiny and some troubling deaths.
Population Health
September 28, 2023
The CDC’s Heavy Obesity Update September 28, 2023
Obesity is easily among the leading cardiovascular disease risk factors, and its overall impact on public cardiovascular health could be rising faster than many of us might imagine. In just 10 years, the U.S. went from having zero states with an obesity prevalence above 35% to a whopping 22 states in 2022.
Cardiology
September 25, 2023
Cardiovascular Societies Seek A Board of Their Own September 25, 2023
After months of growing cardiologist backlash against the ABIM’s Maintenance of Certification program, four leading cardiovascular societies collectively announced plans to create a new cardiology board to replace it.
Pharmaceuticals
September 21, 2023
Abelacimab Significantly Reduces Bleeding September 21, 2023
Anthos Therapeutics celebrated its Phase II results showing that its Factor XI inhibitor abelacimab significantly reduced bleeding among AFib patients compared to rivaroxaban.